Simple blood test may predict Post-Surgery clot risk
NCT ID NCT00901160
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study aimed to see if a blood test called thromboelastography (TEG) and platelet mapping could predict clotting or bleeding complications after non-cardiac surgery. The study included 200 patients who were taking aspirin or clopidogrel for at least 10 days before elective surgery. The goal was to understand if the test results could identify patients at higher risk for complications like heart attack, stroke, or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
200 people
The number who actually took part.
- Started
-
Jan 2008
- Finished
-
Jun 2011
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who are having non-ambulatory, non-cardiac, elective surgery
- Ages
-
40 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients on aspirin and/or clopidogrel for at least 10 days, having non-ambulatory, non-cardiac, elective surgery Exclusion Criteria: * anemia (Hb \< 100) or thrombocytopenia (platelet count \< 80), having any known clotting abnormalities * family history of clotting abnormalities * concurrently on NSAIDs, warfarin therapy or other treatments affecting platelet function * renal impairment (Cr \> 110 mg for females or Cr \> 125 mg) or INR \> 1.2
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Blood clotting are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hamilton Health Sciences
Hamilton, Ontario, L8L 2X2, Canada
-
University Health Network
Toronto, Ontario, M5G 2C4, Canada